Abstract：influenza virus can infect humans and cause disease. The clinical presentation of human infection is usually mild, but the infection caused by A(H5N1) avian influenza virus occurring initially in Hongkong in 1997 or the A(H7N9) virus isolated first at the beginning of this year in China is severe and characterized by high mortality. The mortality rate of adolescents and children caused by H5N1 avian influenza is lower than that of adults and the younger the child the lower the mortality rate. A few pediatric H7N9 avian influenza cases recovered soon after treatment. A child was determined to be a H7N9 avian influenza virus carrier. These findings suggested that the pediatric H7N9 avian influenza infection was mild. It is very important to start anti-virus treatment with oseltamivir as early as possible in cases of avian influenza infection is considered. Combined therapy, including respiratory and circulatory support and inhibiting immunological reaction, is emphasized in the treatment of severe cases.
［3］Cohen J. Influenza. New flu virus in China worries and confuses ［J］. Science, 2013, 340(6129): 129-130.
［4］Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, et al. Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus ［J］. N Engl J Med, 2013 Apr 11. ［DOI: 10.1056/NEJMoa1304459］.
［19］Chan PK, Lee N, Zaman M, Adisasmito W, Coker R, Hanshaoworakul W, et al. Determinants of antiviral effectiveness in influenza virus A subtype H5N1［J］. J Infect Dis, 2012, 206(9): 1359-1366.
